Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma

NCT02980991 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT02980991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02980991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2015
Completion date
April 30, 2018
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung adenocarcinoma